https://www.selleckchem.com/products/n6022.html
To evaluate the long-term developmental trajectory of children with infantile spasms (IS) and identify the clinical protective and risk factors associated with their cognitive outcome. We analyzed the five-year follow-up results of 41 children (13 female) from the previously published cohort (n=68) recruited in a multicenter randomized controlled trial for 2-years, examining the effect of an adjunctive therapy (Flunarizine) on standardized IS treatment. The children were subsequently monitored in an open-label study for additional 3 years
Like
Comment
Share
